Denali Therapeutics

Denali Secures $500M in Financing, Focuses on Large Molecule Biotherapeutics
BioSpace
Tue, 02/27/24 - 11:19 pm
Denali Therapeutics
R&D
large molecule drugs
funding
Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
Reuters
Fri, 02/16/24 - 11:36 am
Denali Therapeutics
Sanofi
ALS
clinical trials
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst
Benzinga
Sun, 09/10/23 - 08:00 pm
Denali Therapeutics
drug deliver
blood-brain barrier
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Wed, 08/9/23 - 11:56 am
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
Biogen buys into Denali’s amyloid beta program
Pharmaphorum
Thu, 04/13/23 - 10:05 am
Biogen
Denali Therapeutics
Alzheimer's disease
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
Motley Fool
Wed, 11/2/22 - 10:51 pm
Denali Therapeutics
clinical trials
Alzheimer's disease
TAK-594
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Biogen
Denali Therapeutics
Parkinson's Disease
clinical trials
BIIB122
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022
BioSpace
Wed, 08/31/22 - 10:19 pm
Denali Therapeutics
clinical trials
DNL310
Hunter Syndrome
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Benzinga
Mon, 02/14/22 - 11:00 am
Denali Therapeutics
FDA
DNL919
clinical hold
Alzheimer's disease
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
Fierce Biotech
Thu, 01/13/22 - 10:19 pm
Denali Therapeutics
Takeda
Alzheimer's disease
FDA
DNL919
Denali Moving Forward with Sanofi-Partnered ALS Candidate
BioSpace
Thu, 10/7/21 - 12:17 pm
Denali Therapeutics
Sanofi
ALS
DNL343
clinical trials
Denali Therapeutics Sees Positive Data in Trial for Enzyme Replacement Therapy
Marketwatch
Mon, 07/26/21 - 09:42 am
Denali Therapeutics
DNL310
enzymes
Hunter Syndrome
clinical trials
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Mon, 05/10/21 - 09:31 pm
Joe Biden
Alzheimer's disease
Denali Therapeutics
Cassava Sciences
Eli Lilly
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Thu, 02/18/21 - 11:04 am
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Denali unveils first proof-of-concept for brain delivery tech in rare disease, with eyes on much bigger indications
Endpoints
Fri, 02/12/21 - 11:08 am
Denali Therapeutics
Hunter Syndrome
proof-of-concept
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Marketwatch
Thu, 08/6/20 - 10:30 am
Denali Therapeutics
Biogen
Parkinson's Disease
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
BioSpace
Thu, 06/11/20 - 10:49 pm
Denali Therapeutics
Sanofi
DNL747
ALS
Alzheimer's disease
DNL788
clinical trials
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Wed, 06/10/20 - 11:00 am
Denali Therapeutics
Genentech
DNL747
Denali unveils new way of crossing blood brain barrier as the big neuroscience bets enter its clinical years
Endpoints
Thu, 05/28/20 - 10:45 am
Denali Therapeutics
Neurosciences
blood-brain barrier

Pages